Earnings History Data for F-star Therapeutics, Inc. (FSTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
F-star Therapeutics, Inc.
F-star Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. F-star Therapeutics Inc., formerly known as Spring Bank Pharmaceuticals Inc., is based in CAMBRIDGE, Mass.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10-05-2022 | PM | 8:00 AM ET (May 10) |
FSTX | F-star Therapeutics, Inc. | 51.95 | -0.57 | -0.63 | -1.08 | F-star Therapeutics GAAP EPS of -$0.57 beats by $0.11, revenue of $2.55M beats by $0.99M [5/10/2022 8:02 AM] |
2.45 | 0.23 (10.36%) |
0.0 | 0.0 (0.00%) |
2.19 - 9.71 | 157,299 | 124,143 | 0 | |
| 14-03-2022 | PM | 8:00 AM ET (Mar 14) |
FSTX | F-star Therapeutics, Inc. | 61.67 | 0.47 | -0.28 | 0.00 | F-star Therapeutics GAAP EPS of -$1.88 beats by $0.37, revenue of $21.17M beats by $5.85M [3/14/2022 8:09 AM] |
2.82 | -0.17 (-5.69%) |
3.20 | 0.21 (7.02%) |
2.75 - 15.50 | 82,946 | 127,938 | 0 | |
| 10-11-2021 | PM | 8:00 AM ET (Nov 10) |
FSTX | F-star Therapeutics, Inc. | 140.63 | -0.52 | -0.56 | 0.00 | F-star Therapeutics EPS beats by $0.06, misses on revenue [11/10/2021 8:20 AM] |
6.21 | -0.44 (-6.62%) |
6.60 | -0.05 (-0.75%) |
3.90 - 15.50 | 258,679 | 220,000 | 411 | |
| 12-08-2021 | PM | 8:00 AM ET (Aug 12) |
FSTX | F-star Therapeutics, Inc. | 112.71 | -0.92 | -0.77 | -1.52 | F-star Therapeutics EPS misses by $0.18, misses on revenue [8/12/2021 8:03 AM] |
6.71 | 0.10 (1.51%) |
6.30 | -0.31 (-4.69%) |
3.88 - 15.50 | 216,747 | 210,000 | 3,334 | |
| 17-05-2021 | PM | Before the open (May 17) |
FSTX | F-star Therapeutics, Inc. | 60.24 | -1.08 | -1.26 | -1.96 | F-star Therapeutics EPS beats by $0.08, beats on revenue [5/17/2021 8:06 AM] |
6.70 | 0.13 (1.98%) |
6.00 | -0.57 (-8.67%) |
3.88 - 15.50 | 177,357 | 390,000 | 4,455 | |
| 29-03-2021 | PM | Before the open (Mar 29) |
FSTX | F-star Therapeutics, Inc. | 125.53 | N/A | -0.55 | -1.80 | F-star Therapeutics EPS misses by $7.92, beats on revenue [3/29/2021 9:17 AM] |
9.42 | -3.43 (-26.69%) |
0.0 | 0.0 (0.00%) |
3.24 - 15.50 | 258,064 | 220,000 | 0 | |